On the 27th, an official at the National Medical Center in Jung-gu, Seoul, is mixing a freeze-dried monkeypox vaccine with an adjuvant. / Photo by Mun Ho-nam munonam@

On the 27th, an official at the National Medical Center in Jung-gu, Seoul, is mixing a freeze-dried monkeypox vaccine with an adjuvant. / Photo by Mun Ho-nam munonam@

View original image

[Asia Economy Reporter Kim Daehyun] The global spread of monkeypox appears to be slowing down.


According to foreign media such as the US Wall Street Journal (WSJ) on the 27th, the international spread of monkeypox has been curbed, and a decline has been observed in major hotspots.


On the 25th, the World Health Organization (WHO) announced that the number of cases, which had been increasing for four consecutive weeks compared to the previous week, has turned to a decline. The number of reported monkeypox cases worldwide from the 15th to the 21st was 5,907, a 21% decrease compared to the previous week (7,477 cases). However, it explained that further confirmation is needed to determine whether the trend of slowing monkeypox spread will continue.



This trend is analyzed to be influenced by vaccination. Ashwin Vasan, the health commissioner of New York City, a major outbreak site in the US, said that vaccination and other infection prevention activities are having a positive effect on slowing the spread of monkeypox.



WHO reported that since the beginning of this year until recently, there have been 41,600 monkeypox cases in 97 countries worldwide. There have been 12 deaths. Monkeypox, which was endemic to the African region, began to appear in non-African regions starting in May. Infection often causes vesicular rash symptoms and may be accompanied by acute fever, headache, and muscle pain.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing